The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Donafenib combined with camrelizumab and transarterial chemoembolization (TACE) as conversion therapy for unresectable hepatocellular carcinoma (uHCC): A prospective, single-arm, phase II study.
 
Yajuan Cao
No Relationships to Disclose
 
Xuebin Zhang
No Relationships to Disclose
 
Yang Yue
No Relationships to Disclose
 
Jin Peng
No Relationships to Disclose
 
Binghua Li
No Relationships to Disclose
 
Jiong Shi
No Relationships to Disclose
 
Min Tang
No Relationships to Disclose
 
Chaobo Chen
No Relationships to Disclose
 
Ke Su
No Relationships to Disclose
 
Laizhu Zhang
No Relationships to Disclose
 
Chunxiao Cheng
No Relationships to Disclose
 
Decai Yu
No Relationships to Disclose